NEC and Biomy Partner to Develop and Expand AI-Based Analytical Platforms in the Digital Pathology Field
TOKYO, Jan 10, 2025 – (JCN Newswire via SeaPRwire.com) – NEC Corporation (NEC; TSE: 6701) and Biomy, Inc. (Biomy) have signed a Memorandum of Understanding (MoU) for a joint marketing partnership to develop and expand artificial intelligence/deep learning (AI/DL)-based analytical platforms in the field of digital pathology(1). Through this partnership, the two companies aim to promote precision medicine for cancer patients and contribute to the advancement of the healthcare industry.BackgroundPrecision medicine, in which more effective treatments with fewer potential side effects are selected based on each patient’s unique characteristics and disease profile, is becoming increasingly prevalent. In pathology diagnostics(2), the use of AI/DL algorithms to analyze digital pathology images is being explored to identify pathological biomarkers(3) that can stratify patients and facilitate the selection of the most patient-tailored and promising treatments and drugs.Objectives of the PartnershipAs a social value cre…















